Subscribe
Monday, October 5, 2026
26.4 C
Bengaluru
type here...
Subscribe
Special Issue
Less than 1 min.Read

Frontline Managers

Anup Soans
By Anup Soans

[wpfilebase tag=file id=62 tpl=download-button /]

Inside this Issue

1. Parle-G: Still Number One by Vivek Hattangadi

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

MedicinMan Market Intelligence

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

0
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Healthcare C-Suite Movements

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

0
With over three decades of experience in the pharmaceutical...
MedicinMan Market Intelligence

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

0
India’s anaemia challenge is not simply about access to...
MedicinMan Market Intelligence

10 Years of Pharma M&A — Who’s Really Benefited?

0
Pharmaceutical M&A is usually discussed in the language of...
Ethics in Healthcare

What’s Killing Patients? Cancer or Rigged Drug Prices?

0
The disease is real. So is the markup. Confusing...

Topics

MedicinMan Market Intelligence

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

0
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Healthcare C-Suite Movements

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

0
With over three decades of experience in the pharmaceutical...
MedicinMan Market Intelligence

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

0
India’s anaemia challenge is not simply about access to...
MedicinMan Market Intelligence

10 Years of Pharma M&A — Who’s Really Benefited?

0
Pharmaceutical M&A is usually discussed in the language of...
Ethics in Healthcare

What’s Killing Patients? Cancer or Rigged Drug Prices?

0
The disease is real. So is the markup. Confusing...
MedicinMan Market Intelligence

A Tale of Two Cities: Peptides and Prescriptions

0
What our health choices reveal about education, access and...
MedicinMan Market Intelligence

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

0
MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...
MedicinMan Market Intelligence

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

0
Private equity does not pay a billion-dollar multiple simply...
spot_img

Related Articles

spot_imgspot_img
Previous article
You can Lead People
Next article
An Invitation from the Editor

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

0
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

0
With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

0
India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

0
Pharmaceutical M&A is usually discussed in the language of...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk